September 12, 2025 - 20:35

In a recent private meeting, the interim CEO and director of Kenvue, the company behind the popular pain reliever Tylenol, engaged in discussions with U.S. Health and Human Services Secretary Robert F. Kennedy Jr. The meeting aimed to address concerns regarding the potential association between the medication and autism. The CEO emphasized that scientific research has not established any clear link between the use of Tylenol and the development of autism spectrum disorders.
The dialogue comes amidst rising scrutiny and ongoing debates surrounding the safety of various medications during pregnancy and early childhood. The CEO's efforts appear to be focused on preventing the inclusion of Tylenol in a forthcoming report that could suggest a connection to autism, a point of contention that has garnered significant public interest and concern.
Both parties acknowledged the importance of continuing to review and analyze existing research to ensure public safety while addressing the anxieties of parents and caregivers.
November 22, 2026 - 00:21
Adam Cole's Wrestling Future in Doubt Amid Health ConcernsAdam Cole may never wrestle again, as ongoing health issues continue to threaten his AEW career. Reports indicate that the talented wrestler has been struggling with significant health problems...
November 21, 2026 - 05:35
Addressing Mental Health Before the Holiday Season`It`s really the silence that`s the problem,` Ray Greenstreet states as he discusses his new book, `Below the Breaking Point.` In a recent conversation with News4`s Jummy Olabanji and Melissa...
November 20, 2026 - 05:21
Resistance Training Shown to Combat Depression More EffectivelyA new study reveals that resistance training could be a significant ally in the fight against depression, potentially offering greater benefits than traditional cardio exercises. Researchers found...
November 19, 2026 - 17:52
Yale New Haven Health taps CEO with strong financial record at UChicagoThomas Jackiewicz has been appointed as the new CEO of Yale New Haven Health, bringing with him a strong track record in financial management. During his time at the University of Chicago Health...